Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

Hamboning0 Apr. 24 at 5:27 PM

$LQDA I’m not bearish at all, however I don’t think this stock is going anywhere anytime soon. And if it does, then it’ll likely be consecutive down days all the way to the mid 20s.

0 · Reply

JFais Apr. 24 at 1:43 PM

$LQDA- buyout on the cheap a real risk here IMO (due in part to perceived ongoing litigation risk with $UTHR) Would much rather give them 2+ years to build out PH-ILD (increasing diagnosis rates into 2030's now that there's a highly efficacious inhaled trepostinil) vs easy exit

2 · Reply

BullRun4 Apr. 24 at 1:01 PM

$LQDA

0 · Reply

KeelinTime Apr. 24 at 1:16 AM

$LQDA

0 · Reply

judgeyoung2 Apr. 23 at 8:40 PM

$LQDA i’m throwing in the towel trying to time this ruling. so expect it by next friday.

1 · Reply

BullRun4 Apr. 23 at 4:11 PM

$LQDA going back up to $38

0 · Reply

gerryh57 Apr. 23 at 1:42 PM

$LQDA anyone anticipating a sales figure? I am thinking 130 million. E*trade was at 116, i think that is too low

3 · Reply

KeelinTime Apr. 23 at 10:55 AM

$LQDA

0 · Reply

SteelerJon Apr. 23 at 12:54 AM

$LQDA 😎🏦🏦Stay Positive

0 · Reply

judgeyoung2 Apr. 22 at 5:28 PM

$LQDA he just uploaded a ruling for first time in 3 weeks. not this one of course.

5 · Reply

Liquidia Transcript: 25th Annual Needham Virtual Healthcare Conference

Mar 6, 2026, 11:17 AM EST - 7 weeks ago

Liquidia Analysts Boost Their Forecasts After Q4 Earnings

Mar 5, 2026, 8:30 AM EST - 7 weeks ago

Liquidia Earnings Call Transcript: Q4 2025

Mar 5, 2026, 6:30 AM EST - 7 weeks ago

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 26, 2026, 7:00 AM EST - 2 months ago

Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026

Jan 14, 2026, 8:15 PM EST - 3 months ago

Liquidia Transcript: 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 8:00 AM EST - 5 months ago

Liquidia Transcript: Jefferies London Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 5 months ago

Liquidia Transcript: UBS Global Healthcare Conference 2025

Nov 3, 2025, 8:30 AM EST - 6 months ago

Liquidia Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:00 AM EST - 6 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Oct 28, 2025, 3:00 PM EDT - 6 months ago

Liquidia Transcript: R&D Day 2025

Oct 27, 2025, 8:30 AM EDT - 6 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 7, 2025, 6:30 AM EDT - 7 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Sep 3, 2025, 3:45 PM EDT - 8 months ago

Liquidia Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 8:30 AM EDT - 8 months ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 13, 2025, 2:51 PM EDT - 9 months ago

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Aug 12, 2025, 2:25 PM EDT - 9 months ago

Why Is Liquidia Stock Trading Higher On Tuesday?

Aug 12, 2025, 8:30 AM EDT - 9 months ago

Liquidia Earnings Call Transcript: Q2 2025

Aug 12, 2025, 6:30 AM EDT - 9 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 23, 2025, 4:34 PM EDT - 10 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 4, 2025, 11:05 AM EDT - 11 months ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 6:30 AM EDT - 11 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 11:08 AM EDT - 11 months ago

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 8:00 AM EDT - 11 months ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 27, 2025, 8:30 AM EDT - 11 months ago

Liquidia Transcript: Status Update

May 23, 2025, 2:28 PM EDT - 1 year ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 13, 2025, 4:40 PM EDT - 1 year ago

Liquidia Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 6:00 AM EDT - 1 year ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q1 2025

May 8, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 2, 2025, 5:28 PM EDT - 1 year ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 9, 2025, 8:45 AM EDT - 1 year ago

Liquidia Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 1 year ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 1 year ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q4 2024

Mar 19, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Nov 19, 2024, 3:00 PM EST - 1 year ago

Liquidia Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings Call Transcript: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 21, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 20, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 19, 2024, 1:30 PM EDT - 1 year ago

Liquidia Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 19, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 18, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Sep 17, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 16, 2024, 9:41 AM EDT - 1 year ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Sep 15, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Investigation

Sep 14, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Inquiring Into Liquidia Corporation's Questionable Practices And Shareholders Should Reach Out

Sep 13, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Violated Securities Regulations And The Schall Law Firm Urges Investors To Partake In An Investigation

Sep 5, 2024, 11:00 AM EDT - 1 year ago

Liquidia Transcript: 2024 Wells Fargo Healthcare Conference

Aug 7, 2024, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q2 2024

Jun 5, 2024, 9:00 AM EDT - 2 years ago

Liquidia Transcript: Jefferies 2024 Global Healthcare Conference

May 14, 2024, 8:00 PM EDT - 2 years ago

Liquidia Transcript: BofA Securities 2024 Health Care Conference

May 14, 2024, 8:30 AM EDT - 2 years ago

Liquidia Earnings Call Transcript: Q1 2024

Apr 9, 2024, 1:30 PM EDT - 2 years ago

Liquidia Transcript: 23rd Annual Needham Virtual Healthcare Conference

Mar 13, 2024, 8:30 AM EDT - 2 years ago

Liquidia Earnings Call Transcript: Q4 2023

Jan 10, 2024, 2:15 PM EST - 2 years ago

Liquidia Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Nov 7, 2023, 8:30 AM EST - 2 years ago

Liquidia Earnings Call Transcript: Q3 2023

Aug 10, 2023, 8:30 AM EDT - 2 years ago

Liquidia Earnings Call Transcript: Q2 2023

Jun 28, 2023, 8:30 AM EDT - 3 years ago

Liquidia Transcript: Status Update

May 4, 2023, 8:30 AM EDT - 3 years ago

Liquidia Earnings Call Transcript: Q1 2023

Mar 16, 2023, 8:30 AM EDT - 3 years ago

Liquidia Earnings Call Transcript: Q4 2022

Nov 8, 2022, 11:00 AM EST - 3 years ago

Liquidia Earnings Call Transcript: Q3 2022

Sep 1, 2022, 8:00 AM EDT - 3 years ago

Liquidia Transcript: Status Update

Aug 11, 2022, 8:30 AM EDT - 4 years ago

Liquidia Earnings Call Transcript: Q2 2022

Jun 16, 2022, 4:30 PM EDT - 4 years ago

Liquidia Transcript: AGM 2022

May 12, 2022, 8:30 AM EDT - 4 years ago

Liquidia Earnings Call Transcript: Q1 2022

Mar 17, 2022, 8:30 AM EDT - 4 years ago

Liquidia Earnings Call Transcript: Q4 2021

Nov 8, 2021, 9:00 AM EST - 4 years ago

Liquidia Transcript: FDA Announcement

Aug 10, 2021, 8:30 AM EDT - 5 years ago

Liquidia Earnings Call Transcript: Q2 2021

Jun 17, 2021, 4:30 PM EDT - 5 years ago

Liquidia Transcript: AGM 2021

May 13, 2021, 8:30 AM EDT - 5 years ago

Liquidia Earnings Call Transcript: Q1 2021

Mar 23, 2021, 8:30 AM EDT - 5 years ago

Liquidia Earnings Call Transcript: Q4 2020

Nov 25, 2020, 9:00 AM EST - 5 years ago

Liquidia Transcript: FDA Announcement

Nov 13, 2020, 4:30 PM EST - 5 years ago

Liquidia Transcript: EGM 2020

Nov 9, 2020, 8:00 AM EST - 5 years ago

Liquidia Earnings Call Transcript: Q3 2020

Aug 10, 2020, 4:30 PM EDT - 6 years ago

Liquidia Earnings Call Transcript: Q2 2020

Jun 30, 2020, 8:00 AM EDT - 6 years ago

Liquidia Transcript: Status Update

Jun 18, 2020, 5:00 PM EDT - 6 years ago

Liquidia Transcript: AGM 2020

May 11, 2020, 4:30 PM EDT - 6 years ago

Liquidia Earnings Call Transcript: Q1 2020

Mar 11, 2020, 8:00 AM EDT - 6 years ago

Liquidia Earnings Call Transcript: Q4 2019

Nov 13, 2019, 8:00 AM EST - 7 years ago

Liquidia Earnings Call Transcript: Q3 2019

Aug 8, 2019, 8:00 AM EDT - 7 years ago

Liquidia Earnings Call Transcript: Q2 2019

May 2, 2019, 8:00 AM EDT - 7 years ago

Liquidia Earnings Call Transcript: Q1 2019

Hamboning0 Apr. 24 at 5:27 PM

$LQDA I’m not bearish at all, however I don’t think this stock is going anywhere anytime soon. And if it does, then it’ll likely be consecutive down days all the way to the mid 20s.

0 · Reply

JFais Apr. 24 at 1:43 PM

2 · Reply

BullRun4 Apr. 24 at 1:01 PM

$LQDA

0 · Reply

KeelinTime Apr. 24 at 1:16 AM

$LQDA

0 · Reply

judgeyoung2 Apr. 23 at 8:40 PM

$LQDA i’m throwing in the towel trying to time this ruling. so expect it by next friday.

1 · Reply

BullRun4 Apr. 23 at 4:11 PM

$LQDA going back up to $38

0 · Reply

gerryh57 Apr. 23 at 1:42 PM

$LQDA anyone anticipating a sales figure? I am thinking 130 million. E*trade was at 116, i think that is too low

3 · Reply

KeelinTime Apr. 23 at 10:55 AM

$LQDA

0 · Reply

SteelerJon Apr. 23 at 12:54 AM

$LQDA 😎🏦🏦Stay Positive

0 · Reply

judgeyoung2 Apr. 22 at 5:28 PM

$LQDA he just uploaded a ruling for first time in 3 weeks. not this one of course.

5 · Reply

BullRun4 Apr. 22 at 1:06 PM

$LQDA

0 · Reply

Ceherring Apr. 22 at 11:16 AM

$LQDA

0 · Reply

KeelinTime Apr. 22 at 11:09 AM

$LQDA

0 · Reply

Hamboning0 Apr. 21 at 6:02 PM

$LQDA

2 · Reply

SteelerJon Apr. 21 at 11:22 AM

$LQDA 😎🏦🏦 https://seekingalpha.com/article/4892235-liquidia-corp-prime-candidate-for-a-takeout-by-large-pharma

2 · Reply

Pickin Apr. 21 at 9:02 AM

$MNKD so apparently there’s an upcoming ruling in the ongoing $LQDA and $UTHR lawsuit. I hope Martin gets his balls kicked in for treating his partner Mannkind like he did. I suppose he could be a eunuch so he might not get the full effect but let’s give it a try.

2 · Reply

judgeyoung2 Apr. 20 at 8:13 PM

$LQDA someone knock on his door. fwiw BOFA analyst is predicting +/-25% on the ruling. iv did ramp a bit today. calls didn’t lose as much as they should have.

1 · Reply

Hamboning0 Apr. 20 at 6:58 PM

$LQDA

0 · Reply

Hamboning0 Apr. 20 at 6:01 PM

$LQDA RIP LQDA. I unfortunately don’t think we’ll be seeing the 40s again anytime soon. However, I do think we’ll be seeing the low 30s sooner than later.

2 · Reply

leafmccarthurJD Apr. 20 at 1:30 AM

$LQDA guys, I heard from a source, that Judge Andrews has a vacation home on the strait, and has been quote “stranded” in the Middle East for almost 3 weeks now. My sources went on to tell me that, the IRGC has a huge long in UTHR, and is holding the judge at gun point… let’s see how this plays out

2 · Reply

BullRun4 Apr. 19 at 5:22 PM

$LQDA OSTradeZ on X: Broke above the $39 resistance after a one-month consolidation. Next target is the prior high at $47. Verdict: Setup suggests a swing long. Very bullish set up! https://x.com/ostradez/status/2042587297678610823?s=46

0 · Reply

BioTechHealthX Apr. 19 at 2:40 AM

$LQDA Liquidia Corporation is quietly approaching a major turning point with its advanced drug delivery platform and near-commercial-stage pipeline. As regulatory momentum builds, this overlooked biotech stock could be closer to a breakout than investors realize. https://biotechhealthx.com/biotech-news/is-it-a-great-move-to-acquire-liquidia-corporation-lqda-shares/

0 · Reply

Market Cap	3.30B
Revenue (ttm)	158.32M
Net Income (ttm)	-68.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	21.18
Profit Margin	-43.53%
Debt to Equity Ratio	4.28

Volume	710,900
Avg Vol	1,476,596
Day's Range	N/A - N/A
Shares Out	88.11M
Stochastic %K	24%
Beta	0.45
Analysts	Strong Sell
Price Target	$50.67